Sports Medicine

, Volume 40, Issue 3, pp 207–227 | Cite as

The Effect of the Menstrual Cycle on Exercise Metabolism

Implications for Exercise Performance in Eumenorrhoeic Women
  • Tanja OosthuyseEmail author
  • Andrew N. Bosch
Review Article


The female hormones, oestrogen and progesterone, fluctuate predictably across the menstrual cycle in naturally cycling eumenorrhoeic women. Other than reproductive function, these hormones influence many other physiological systems, and their action during exercise may have implications for exercise performance. Although a number of studies have found exercise performance — and in particular, endurance performance — to vary between menstrual phases, there is an equal number of such studies reporting no differences. However, a comparison of the increase in the oestrogen concentration (E) relative to progesterone concentration (P) as the E/P ratio (pmol/ nmol) in the luteal phase in these studies reveals that endurance performance may only be improved in the mid-luteal phase compared with the early follicular phase when the E/P ratio is high in the mid-luteal phase. Furthermore, the late follicular phase, characterized by the pre-ovulatory surge in oestrogen and suppressed progesterone concentrations, tends to promote improved performance in a cycling time trial and future studies should include this menstrual phase. Menstrual phase variations in endurance performance may largely be a consequence of changes to exercise metabolism stimulated by the fluctuations in ovarian hormone concentrations. The literature suggests that oestrogen may promote endurance performance by altering carbohydrate, fat and protein metabolism, with progesterone often appearing to act antagonistically. Details of the ovarian hormone influences on the metabolism of these macronutrients are no longer only limited to evidence from animal research and indirect calorimetry but have been verified by substrate kinetics determined with stable tracer methodology in eumenorrhoeic women. This review thoroughly examines the metabolic perturbations induced by the ovarian hormones and, by detailed comparison, proposes reasons for many of the inconsistent reports in menstrual phase comparative research. Often the magnitude of increase in the ovarian hormones between menstrual phases and the E/P ratio appear to be important factors determining an effect on metabolism. However, energy demand and nutritional status may be confounding variables, particularly in carbohydrate metabolism. The review specifically considers how changes in metabolic responses due to the ovarian hormones may influence exercise performance. For example, oestrogen promotes glucose availability and uptake into type I muscle fibres providing the fuel of choice during short duration exercise; an action that can be inhibited by progesterone. A high oestrogen concentration in the luteal phase augments muscle glycogen storage capacity compared with the low oestrogen environment of the early follicular phase. However, following a carbo-loading diet will super-compensate muscle glycogen stores in the early follicular phase to values attained in the luteal phase. Oestrogen concentrations of the luteal phase reduce reliance on muscle glycogen during exercise and although not as yet supported by human tracer studies, oestrogen increases free fatty acid availability and oxidative capacity in exercise, favouring endurance performance. Evidence of oestrogen’s stimulation of 50-AMPactivated protein kinase may explain many of the metabolic actions of oestrogen. However, both oestrogen and progesterone suppress gluconeogenic output during exercise and this may compromise performance in the latter stages of ultra-long events if energy replacement supplements are inadequate. Moreover, supplementing energy intake during exercise with protein may be more relevant when progesterone concentration is elevated compared with menstrual phases favouring a higher relative oestrogen concentration, as progesterone promotes protein catabolism while oestrogen suppresses protein catabolism. Furthermore, prospective research ideas for furthering the understanding of the impact of the menstrual cycle on metabolism and exercise performance are highlighted.


Luteal Phase Muscle Glycogen Ovarian Hormone Plasma Free Fatty Acid Endogenous Glucose Production 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



Studies cited in this review as unpublished findings were supported by grants from the University of the Witwatersrand Research Council, Medical Research Council of South Africa and the National Research Foundation. The authors have no conflicts of interest that are directly relevant to the content of this review.


  1. 1.
    Reilly T. The menstrual cycle and human performance: an overview. Biol Rhythm Res 2000; 31: 29–40CrossRefGoogle Scholar
  2. 2.
    Lebrun CM. The effect of the phase of the menstrual cycle and the birth control pill on athletic performance. Clin Sports Med 1994; 13: 419–41PubMedGoogle Scholar
  3. 3.
    Buffenstein R, Poppott SD, McDevitt, RM et al. Food intake and themenstrual cycle: a retrospective analysis, with implications for appetite research. Physiol Behav 1995; 58: 1067–77PubMedCrossRefGoogle Scholar
  4. 4.
    Birch K. Circamensal rhythms in physical performance. Biol Rhythm Res 2000; 31: 1–14CrossRefGoogle Scholar
  5. 5.
    Jurkowski JEH, Jones NL, Toews CJ, et al. Effects of menstrual cycle on blood lactate, O2 delivery, and performance during exercise. J Appl Physiol 1981; 51: 1439–99Google Scholar
  6. 6.
    Bemben DA, Salm PC, Salm AJ. Ventilatory and blood lactate responses to maximal treadmill exercise during the menstrual cycle. J Sports Med Phys Fitness 1995; 35: 257–62PubMedGoogle Scholar
  7. 7.
    Dean TM, Perreault L, Mazzeo RS, et al. No effect of menstrual cycle phase on lactate threshold. J Appl Physiol 2003; 95: 2537–43PubMedGoogle Scholar
  8. 8.
    De Souza MJ, Maguire MS, Rubin K. Effects of menstrual phase and amenorrhea on exercise responses in runners. Med Sci Sports Exerc 1990; 22: 575–80PubMedCrossRefGoogle Scholar
  9. 9.
    Beidleman BA, Rock PB, Muza SR, et al. Exercise VE and physical performance at altitude are not affected by menstrual cycle phase. J Appl Physiol 1999; 86: 1519–26PubMedGoogle Scholar
  10. 10.
    Casazza GA, Suh S-H, Miller BF, et al. Effects of oral contraceptives on peak exercise capacity. J Appl Physiol 2002; 93: 1698–702PubMedGoogle Scholar
  11. 11.
    Dombovy ML, Bonekat HW, Williams TJ. Exercise performance and ventilatory response in the menstrual cycle. Med Sci Sport Exerc 1987; 19: 111–7CrossRefGoogle Scholar
  12. 12.
    Schoene RB, Robertson HT, Pierson DJ, et al. Respiratory drives and exercise in menstrual cycles of athletic and nonathletic women. J Appl Physiol 1981; 50: 1300–5PubMedGoogle Scholar
  13. 13.
    Smekal G, Von Duvillard SP, Frigo P, et al. Menstrual cycle: no effect on exercise cardiorespiratory variables or blood lactate concentration. Med Sci Sports Exerc 2007; 39 (7): 1098–106PubMedCrossRefGoogle Scholar
  14. 14.
    Lebrun CM, McKenzie DC, Prior JC, et al. Effects of menstrual cycle phase on athletic performance. Med Sci Sports Exerc 1995; 27: 437–44PubMedGoogle Scholar
  15. 15.
    Brutsaert TD, Spielvogel H, Caceres E, et al. Effect of menstrual cycle phase on exercise performance of highaltitude native women. J Exp Biol 2002; 202: 233–9Google Scholar
  16. 16.
    Stanford KI, Mickleborough TD, Ray S, et al. Influence of menstrual cycle phase on pulmonary function in asthmatic athletes. Eur J Appl Physiol; 96: 703–10Google Scholar
  17. 17.
    Oosthuyse T, Bosch AN. Influence of menstrual phase on ventilatory responses to submaximal exercise. S Afr J Sports Med 2006; 18: 31–7Google Scholar
  18. 18.
    Forsyth JJ, Reilly T. The combined effect of time of day and menstrual cycle on lactate threshold. Med Sci Sports Exerc 2005; 37 (12): 2046–53PubMedCrossRefGoogle Scholar
  19. 19.
    Zderic TW, Coggan AR, Ruby BC. Glucose kinetics and substrate oxidation during exercise in the follicular and luteal phases. J Appl Physiol 2001; 90: 447–53PubMedGoogle Scholar
  20. 20.
    Lavoie J-M, Dionne N, Helie R, et al. Menstrual cycle phase dissociation of blood glucose homeostasis during exercise. J Appl Physiol 1987; 62: 1084–9PubMedCrossRefGoogle Scholar
  21. 21.
    McCracken M, Ainsworth B, Hackney AC. Effects of the menstrual cycle phase on the blood lactate response to exercise. Eur J Appl Physiol 1994; 69: 174–5CrossRefGoogle Scholar
  22. 22.
    Campbell SE, Angus DJ, Febbraio MA. Glucose kinetics and exercise performance during phases of the menstrual cycle: effect of glucose ingestion. Am J Physiol 2001; 281: E817–25Google Scholar
  23. 23.
    Nicklas BJ, Hackney AC, Sharp RL. The menstrual cycle and exercise: performance, muscle glycogen, and substrate responses. Int J Sports Med 1989; 10: 264–9PubMedCrossRefGoogle Scholar
  24. 24.
    Suh S-H, Casazza GA, Horning MA, et al. Effects of oral contraceptives on glucose flux and substrate oxidation rates during rest and exercise. J Appl Physiol 2002; 93: 42–50PubMedGoogle Scholar
  25. 25.
    Horton TJ, Miller EK, Glueck D, et al. No effect of menstrual cycle phase on glucose kinetics and fuel oxidation during moderate-intensity exercise. Am J Physiol 2002; 282: E752–62Google Scholar
  26. 26.
    Brooks-Gunn J, Gargiulo JM, Warren MP. The effect of cycle phase in the performance of adolescent swimmers. Physician Sportsmed 1986; 14: 182–4Google Scholar
  27. 27.
    Davies BN, Elford JC, Jamieson KF. Variations in performance in simple muscle tests at different phases of the menstrual cycle. J Sports Med Phys Fitness 1991; 31 (4): 532–7PubMedGoogle Scholar
  28. 28.
    Redman LM, Weatherby RP. Measuring performance during the menstrual cycle: a model using oral contraceptives. Med Sci Sports Exerc 2004; 36 (1): 130–6PubMedCrossRefGoogle Scholar
  29. 29.
    Bushman B, Masterson G, Nelsen J. Anaerobic power performance and the menstrual cycle: eumenorrheic and oral contraceptive users. J Sports Med Phys Fitness 2006; 46 (1): 132–7PubMedGoogle Scholar
  30. 30.
    Middleton LE, Wenger HA. Effects of menstrual phase on performance and recovery in intense intermittent activity. Eur J Appl Physiol 2006; 96: 53–8PubMedCrossRefGoogle Scholar
  31. 31.
    Kendrick ZV, Steffen CA, Rumsey WL, et al. Effect of estradiol on tissue glycogen metabolism in exercised oophorectomized rats. J Appl Physiol 1987; 63: 492–6PubMedGoogle Scholar
  32. 32.
    Jeukendrup A, Saris WHM, Brouns F, et al. A new validated endurance performance test. Med Sci Sports Exerc 1996; 28 (2): 266–70PubMedCrossRefGoogle Scholar
  33. 33.
    Bailey SP, Zacher CM, Mittleman KD. Effect of menstrual cycle phase on carbohydrate supplementation during prolonged exercise to fatigue. J Appl Physiol 2000; 88: 690–7PubMedGoogle Scholar
  34. 34.
    McLay RT, Thomson CD, Williams SM, et al. Carbohydrate loading and female endurance athletes: effect of menstrual-cycle phase. Int J Sport Nutr Exerc Metab 2007; 17 (2): 189–205PubMedGoogle Scholar
  35. 35.
    Oosthuyse T, Bosch AN, Jackson S. Cycling time trial performance during different phases of the menstrual cycle. Eur J Appl Physiol 2005; 94: 268–76PubMedCrossRefGoogle Scholar
  36. 36.
    Ruby BC, Robergs RA, Waters DL, et al. Effects of estradiol on substrate turnover during exercise in amenorrheic females. Med Sci Sports Exerc 1997; 29: 1160–9PubMedCrossRefGoogle Scholar
  37. 37.
    Devries MC, Hamadeh MJ, Graham TE, et al. 17b-estradiol supplementation decreases glucose rate of appearance and disappearance with no effect on glycogen utilization during moderate intensity exercise in men. J Clin Endo Metab 2005; 90: 6218–25CrossRefGoogle Scholar
  38. 38.
    Palmer GS, Dennis SC, Noakes TD, et al. Assessment of the reproducibility of performance testing on an air-braked cycle ergometer. Int J Sports Med 1996; 17: 293–8PubMedCrossRefGoogle Scholar
  39. 39.
    Campbell SE, Febbraio MA. Effect of the ovarian hormones on GLUT4 expression and contraction-stimulated glucose uptake. Am J Physiol 2002; 282: E1139–46Google Scholar
  40. 40.
    Campbell SE, Febbraio MA. Effect of ovarian hormones on mitochondrial enzyme activity in fat oxidation pathway of skeletal muscle. Am J Physiol 2001; 281: E803–8Google Scholar
  41. 41.
    Hatta H, Atomi Y, Shinohara S, et al. The effects of ovarian hormones on glucose and fatty acid oxidation during exercise in female ovariectomized rats. Horm Metab Res 1988; 20: 609–11PubMedCrossRefGoogle Scholar
  42. 42.
    D’Eon TM, Sharoff C, Chipkin SR, et al. Regulation of exercise carbohydrate metabolism by estrogen and progesterone in women. Am J Physiol 2002; 283: E1046–55Google Scholar
  43. 43.
    Carter SL, McKenzie S, Mourtzakis M, et al. Short-term 17b-estradiol decreases glucose Ra but not whole body metabolism during endurance exercise. J Appl Physiol 2001; 90: 139–46PubMedGoogle Scholar
  44. 44.
    Devries MC, Mazen JH, Phillips SM, et al. Menstrual cycle phase and sex influence muscle glycogen utilization and glucose turnover during moderate-intensity endurance exercise. Am J Physiol 2006; 291: R1120–8Google Scholar
  45. 45.
    Matute ML, Kalkhoff RK. Sex steroid influence on hepatic gluconeogenesis and glycogen formation. Endocrinology 1973; 92: 762–8PubMedCrossRefGoogle Scholar
  46. 46.
    Friedlander AL, Casazza GA, Horning MA, et al. Training- induced alterations of carbohydrate metabolism in women: women respond differently from men. J Appl Physiol 1998; 85 (3): 1175–86PubMedGoogle Scholar
  47. 47.
    Hackney AC. Influence of oestrogen on muscle glycogen utilization during exercise. Acta Physiol Scand 1999; 167: 273–4PubMedCrossRefGoogle Scholar
  48. 48.
    Hackney AC. Effects of the menstrual cycle on resting muscle glycogen content. Horm Metab Res 1990; 22: 647PubMedCrossRefGoogle Scholar
  49. 49.
    Tarnopolsky MA, Roy BD, MacDonald JR, et al. Short-term 17-b-estradiol administration does not affect metabolism in young males. Int J Sports Med 2001; 22: 175–80PubMedCrossRefGoogle Scholar
  50. 50.
    Shimomura K, Shimizu H, Tsuchiya T, et al. Is leptin a key factor which develops obesity by ovariectomy? Endocr J 2002; 49 (4): 417–23PubMedCrossRefGoogle Scholar
  51. 51.
    Rooney TP, Kendrick ZV, Carlson J, et al. Effect of estradiol on the temporal pattern of exercise-induced tissue glycogen depletion in male rats. J Appl Physiol 1993; 75: 1502–6PubMedGoogle Scholar
  52. 52.
    Beckett T, Tchernof A, Tchernof A. Effect of ovariectomy and estradiol replacement on skeletal muscle enzyme activity in female rats. Metabolism 2002; 51 (11): 1397–401PubMedCrossRefGoogle Scholar
  53. 53.
    Latour MG, Shinoda M, Lavoie J-M. Metabolic effects of physical training in ovariectomized and hyperestrogenic rats. J Appl Physiol 2001; 90: 235–41PubMedGoogle Scholar
  54. 54.
    Van Pelt RE, Gozansky WS, Schwartz RS, et al. Intravenous estrogens increase insulin clearance and action in postmenopausal women. Am J Physiol 2003; 285: E311–7Google Scholar
  55. 55.
    Hansen PA, McCarthy TJ, Pasia EN, et al. Effects of ovariectomy and exercise training on muscle GLUT-4 content and glucose metabolism in rats. J Appl Physiol 1996; 80: 1605–11PubMedCrossRefGoogle Scholar
  56. 56.
    Cooper BC, Sites CK, Casson PR, et al. Ovarian suppression with a gonadotropin-releasing hormone agonist does not alter insulin-stimulated glucose disposal. Fertil Steril 2007; 87 (5): 1131–8PubMedCrossRefGoogle Scholar
  57. 57.
    Toth MJ, Cooper BC, Partley RE, et al. Effect of ovarian suppression with gonadotropin-releasing hormone agonist on glucose disposal and insulin secretion. Am J Physiol 2008; 294: E1035–45Google Scholar
  58. 58.
    Kalkhoff RK. Metabolic effects of progesterone. Am J Obstet Gynecol 1982; 142: 735–8PubMedGoogle Scholar
  59. 59.
    Elkind Hirsch KE, Sherman LD, Malinak R. Hormone replacement therapy alters insulin sensitivity in young women with premature ovarian failure. J Clin Endocrinol Metab 1993; 76: 472–5PubMedCrossRefGoogle Scholar
  60. 60.
    Ezenwaka EC, Akanji AO, Adejuwon CA, et al. Insulin responses following glucose administration in menstruating women. Int J Gynaecol Obstet 1993; 42: 155–9PubMedCrossRefGoogle Scholar
  61. 61.
    Hackney AC, Curley CS, Nicklas BJ. Physiological responses to submaximal exercise at the mid-follicular, ovulatory and mid-luteal phases of the menstrual cycle. Scand J Med Sci Sports 1991; 1: 94–8CrossRefGoogle Scholar
  62. 62.
    Horton TJ, Miller EK, Bourret K. No effect of menstrual cycle phase on glycerol or palmitate kinetics during 90min of moderate exercise. J Appl Physiol 2006; 100: 917–25PubMedCrossRefGoogle Scholar
  63. 63.
    Jacobs KA, Casazza GA, Suh S-H, et al. Fatty acid reesterification but not oxidation is increased by oral contraceptive use in women. J Appl Physiol 2005; 98: 1720–31PubMedCrossRefGoogle Scholar
  64. 64.
    Wolfe RR. Radioactive and stable isotope tracers in biomedicine: principles and practice of kinetic analysis. New York: Wiley-Liss, Incorporated, 1992Google Scholar
  65. 65.
    Landau BR, Wahren J, Previs SF, et al. Glycerol production and utilization in humans: sites and quantification. Am J Physiol 1996; 271: E1110–7Google Scholar
  66. 66.
    Elia M, Kahn K, Calder G, et al. Glycerol exchange across the human forearm assessed by a combination of tracer and arteriovenous exchange techniques. Clin Sci 1993; 84: 99–104PubMedGoogle Scholar
  67. 67.
    Casazza GA, Jacobs KA, Suh S-H, et al. Menstrual cycle phase and oral contraceptive effects on triglyceride mobilization during exercise. J Appl Physiol 2004; 97: 302–9PubMedCrossRefGoogle Scholar
  68. 68.
    Hellström L, Blaak E, Hagström-Toft E. Gender differences in adrenergic regulation of lipid mobilization during exercise. Int J Sports Med 1996; 17: 439–47PubMedCrossRefGoogle Scholar
  69. 69.
    Mittendorfer B, Horowitz JF, Klein S. Effect of gender on lipid kinetics during endurance exercise of moderate intensity in untrained subjects. Am J Physiol 2002; 283: E58–65Google Scholar
  70. 70.
    Haffner SM, Valdez RA. Endogenous sex hormones: impact on lipids, lipoproteins, and insulin. Am J Med 1995; 98: 40S–7SPubMedCrossRefGoogle Scholar
  71. 71.
    Faria ACS, Bekenstein LW, Booth Jr RA, et al. Pulsatile growth hormone release in normal women during the menstrual cycle. Clin Endocrin 1992; 36: 591–6CrossRefGoogle Scholar
  72. 72.
    Benoit V, Valette A, Mercier L, et al. Potentiation of epinephrine-induced lipolysis in fat cells from estrogen-treated rats. Biochem Biophys Res Comm 1982; 109: 1186–91PubMedCrossRefGoogle Scholar
  73. 73.
    Hansen FM, Fahmy N, Nielsen JH. The influence of sexual hormones on lipogenesis and lipolysis in rat fat cells. Acta Endocrin 1980; 95: 566–70Google Scholar
  74. 74.
    Ellis GS, Lanza-Jacoby S, Gow A, et al. Effects of estradiol on lipoprotein lipase activity and lipid availability in exercised male rats. J Appl Physiol 1994; 77: 209–15PubMedGoogle Scholar
  75. 75.
    Spriet LL. Regulation of fat/carbohydrate interaction in human skeletal muscle during exercise. Adv Exp Med Biol 1998; 441: 249–61PubMedGoogle Scholar
  76. 76.
    Romijn JA, Coyle EF, Sidossis LS, et al. Substrate metabolism during different exercise intensities in endurancetrained women. J Appl Physiol 2000; 88: 1707–14PubMedGoogle Scholar
  77. 77.
    Romijn JA, Coyle EF, Sidossis LS, et al. Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration. AmJ Physiol 1993; 265: E380–91Google Scholar
  78. 78.
    Friedlander AL, Casazza GA, Horning MA, et al. Effects of exercise intensity and training on lipid metabolism in young women. J Appl Physiol 1998; 275: E853–63Google Scholar
  79. 79.
    Heiling VJ, Jensen MD. Free fatty acid metabolism in the follicular and luteal phases of the menstrual cycle. J Clin Endocrinol Metab 1992; 74: 806–10PubMedCrossRefGoogle Scholar
  80. 80.
    Jensen MD, Martin ML, Cryer PE, et al. Effects of estrogen on free fatty acid metabolism in humans. Am J Physiol 1994; 266: E914–20Google Scholar
  81. 81.
    Magkos F, Patterson BW, Mittendorfer B. No effect of menstrual cycle phase on basal very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics. Am J Physiol 2006; 291: E1243–9Google Scholar
  82. 82.
    Uranga AP, Levine J, Jensen M. Isotope tracer measures of meal fatty acid metabolism: reproducibility and effects of the menstrual cycle. Am J Physiol 2005; 288: E547–55Google Scholar
  83. 83.
    D’Eon TM, Souza SC, Aronovitz M, et al. Estrogen regulation of adiposity and fuel partitioning: evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J Biol Chem 2005; 280 (43): 35983–91PubMedCrossRefGoogle Scholar
  84. 84.
    Sidossis LS, Coggan AR, Gastadelli A, et al. A new correction factor for use in tracer estimations of plasma fatty acid oxidation. Am J Physiol 1995; 269: E649–56Google Scholar
  85. 85.
    Oosthuyse T, Bosch AN, Jackson S. Effect of menstrual phase on the acetate correction factor used in metabolic tracer studies. Can J Appl Physiol 2003; 28: 818–30PubMedCrossRefGoogle Scholar
  86. 86.
    Lamont LS, Lemon PWR, Bruot BC. Menstrual cycle and exercise effects on protein catabolism. Med Sci Sports Exerc 1987; 19: 106–10PubMedGoogle Scholar
  87. 87.
    White LJ, Ferguson MA, McCoy S, et al. Intramyocellular lipid changes in men and women during aerobic exercise: a 1H-magnetic resonance spectroscopy study. J Clin Endocrinol Metab 2003; 88: 5638–43PubMedCrossRefGoogle Scholar
  88. 88.
    Tarnopolsky MA, Rennie CD, Robertshaw HA, et al. Influence of endurance exercise training and sex on intramyocellular lipid and mitochondrial ultrastructure, substrate use, and mitochondrial enzyme activity. Am J Physiol 2007; 292 (3): R1271–8Google Scholar
  89. 89.
    Devries MC, Lowther SA, Glover AW, et al. IMCL area density, but not IMCL utilization, is higher in women during moderate-intensity endurance exercise, compared with men. Am J Physiol 2007; 293 (6): R2336–42Google Scholar
  90. 90.
    Zehnder M, Ith M, Kreis R, et al. Gender-specific usage of intramyocellular lipids and glycogen during exercise. Med Sci Sports Exerc 2005; 37 (9): 1517–24PubMedCrossRefGoogle Scholar
  91. 91.
    Forsberg AM, Nilsson E, Werneman J, et al. Muscle composition in relation to age and sex. Clin Sci 1991; 81: 249–56PubMedGoogle Scholar
  92. 92.
    Roepstorff C, Steffensen CH, Madsen M, et al. Gender differences in substrate utilization during submaximal exercise in endurance-trained subjects. AmJ Physiol 2002; 282: E435–47Google Scholar
  93. 93.
    Roepstorff C, Donsmark M, Thiele M, et al. Sex differences in hormone-sensitive lipase expression, activity, and phosphorylation in skeletal muscle at rest and during exercise. Am J Physiol 2006; 291: E1106–14Google Scholar
  94. 94.
    Steffensen CH, Roepstorff C, Madsen M, et al. Myocellular triacylglycerol breakdown in females but not in males during exercise. Am J Physiol 2002; 282: E634–42Google Scholar
  95. 95.
    Jrgensen SB, Richter EA, Wojtaszewski JFP. Role of AMPK in skeletal muscle metabolism regulation and adaptation in relation to exercise. J Physiol 2006; 574 (1): 17–31CrossRefGoogle Scholar
  96. 96.
    Steinberg GR, Macaulay SL, Febbraio MA, et al. AMP activated protein kinase: the fat controller of the energy railroad. Can J Physiol Pharmacol 2006; 84: 655–65PubMedCrossRefGoogle Scholar
  97. 97.
    Roepstorff C, Thiele M, Hillig T, et al. Higher skeletal muscle a2AMPK activation and lower energy charge and fat oxidation in men than in women during submaximal exercise. J Physiol 2006; 574 (1): 125–38PubMedCrossRefGoogle Scholar
  98. 98.
    Wiik A, Gustafsson T, Esbjo rnssonM, et al. Expression of oestrogen receptor alpha and beta is higher in skeletal muscle of highly endurance-trained than of moderately active men. Acta Physiol Scand 2005; 184 (2): 105–12PubMedCrossRefGoogle Scholar
  99. 99.
    Combs TP, Berg AH, Rajala MW, et al. Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 2003; 52: 268–76PubMedCrossRefGoogle Scholar
  100. 100.
    Kleiblova P, Springer D, Haluzik M. The influence of hormonal changes during menstrual cycle on serum adiponectin concentration in healthy women. Physiol Res 2006; 55: 661–6PubMedGoogle Scholar
  101. 101.
    Kriengsinyos W, Wykes LJ, Goonewardene LA, et al. Phase of menstrual cycle affects lysine requirement in healthy women. Am J Physiol 2004; 287: E489–96Google Scholar
  102. 102.
    Lariviere F, Moussalli R, Garrel DR. Increased leucine flux and leucine oxidation during the luteal phase of the menstrual cycle in women. Am J Physiol 1994; 267: E422–8Google Scholar
  103. 103.
    Toth MJ, Sites CK, Matthews DE, et al. Ovarian suppression with gonadotropin-releasing hormone agonist reduces whole body protein turnover in women. Am J Physiol 2006; 291: E483–90CrossRefGoogle Scholar
  104. 104.
    Hamadeh MJ, Devries MC, Tarnopolsky MA. Estrogen supplementation reduces whole body leucine and carbohydrate oxidation and increases lipid oxidation in men during endurance exercise. J Clin Endocrinol Metab 2005; 90 (6): 3592–9PubMedCrossRefGoogle Scholar
  105. 105.
    Miller BF, Hansen M, Olesen JL, et al. No effect of menstrual cycle on myofibrillar and connective tissue protein synthesis in contracting skeletal muscle. Am J Physiol 2006; 290: E163–8Google Scholar

Copyright information

© Adis Data Information BV 2010

Authors and Affiliations

  1. 1.School of PhysiologyUniversity of the Witwatersrand Medical SchoolNorthriding 2162, JohannesburgSouth Africa
  2. 2.UCT/MRC Research Unit for Exercise Science and Sports MedicineUniversity of Cape TownCape TownSouth Africa

Personalised recommendations